Effective November 29, 2021, Anya Goldin, resigned from her position as a member of the board of directors of Cure Pharmaceutical Holding Corp. (the “Company”), and from her positions as a member of the Compensation committee and Nominating and Governance committee. Effective November 30, 2021, Lauren Chung resigned from her position as a member of the Board, and from her positions as a member of the Audit committee, and as Chair of the Compensation and Nominating and Governance committees.